Organization profile
Organization profile
Our mission at the Fox Chase - Temple Urologic Institute is to lead the way in urologic care, education, and research across the Delaware Valley and beyond. We are committed to expanding access to advanced urologic care for patients across the region, integrating urology across the Temple Health system under the banner of Fox Chase-Temple Health Urologic Institute, attracting top talent to our premier fellowships and growing the Temple Urology residency. At the heart of our mission is a commitment to research excellence, through building a dynamic research portfolio that opens new trials, obtains grant support, and maintains some of the largest clinical databases in the world. The Temple Urologic Institute is lead by Alexander Kutikov, MD.
Fingerprint
Dive into the research topics where Fox Chase - Temple Urologic Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
0.05% Chlorhexidine gluconate is not associated with infection in antibiotic impregnated inflatable penile prosthesis surgery: results from a large multi-institutional collaborative
Ivan, S. J., Abou Chawareb, E., Hammad, M., Lesgart, M., Baird, B., Bajic, P., Barham, D. W., Bernie, H. L., Bole, R., Chung, P., Cowan, K., Dominick, Z., Good, J., Helo, S., Hsieh, M. H., Im, B. H., Kadakia, Y., Kohler, T., Lentz, A. C. & Mass-Lindenbaum, M. & 15 others, , Jan 5 2026, In: Journal of Sexual Medicine. 23, 1, qdaf368.Research output: Contribution to journal › Article › peer-review
-
A 64-Year-Old Woman with Fatigue and Dyspnea
Kim, H. S., Ghiraldi, E. M., Winn, J. S. & Nakhoda, S., Jan 2026, In: NEJM Evidence. 5, 1, p. EVIDmr2500153Research output: Contribution to journal › Article › peer-review
-
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer
Chapin, B. F., Smaldone, M., Zurita, A. J., Wang, J., Cooperberg, M. R., Gleave, M., Delacroix, S. E., Davis, J., Pettaway, C., Pisters, L., Adibi, M., Chery, L., Papadopoulos, J., Ward, J., Gregg, J., Navai, N., Corn, P., Subudhi, S. K., Logothetis, C. & Kuban, D. & 18 others, , 2026, (Accepted/In press) In: European Urology.Research output: Contribution to journal › Article › peer-review
Prizes
-
-
-
Carol and Louis Della Penna Chair in Urologic Oncology
Chen, D. Y. (Recipient), Apr 21 2025
Prize: Other distinction
Press/Media
-
Two Major Cancer Centers Announce Appointments of New Directors
03/30/26
1 item of Media coverage
Press/Media
-
-
Temple Health Appoints Robert A. Winn, MD, as Cancer Center Director for Fox Chase Cancer Center
03/19/26
1 item of Media coverage
Press/Media